英格兰和威尔士类风湿关节炎缓解率趋势:一项人群水平队列研究
该观察性队列研究利用2018年5月至2024年4月英格兰和威尔士国家早期炎性关节炎审计(NEIAA)数据,评估新诊断类风湿关节炎(RA)患者缓解率的时间趋势、地理差异及预测因素。21904例RA患者中13752例(62.8%)有初次风湿科评估后3个月DAS28数据,其中4764例(34.6%)达到缓解。全国缓解率2018至2024年保持稳定,但地区间差异大,从伦敦28.4%到英格兰东部40.3%,地区内各医院间缓解率相差三倍。
要点
- 全国早期RA缓解率2018至2024年保持稳定,但地区差异显著,伦敦28.4% vs 英格兰东部40.3%。
- 地区内不同医院间缓解率相差三倍。
- 较年轻、女性、Black ethnicity、较高基线DAS28、延迟启用DMARD及较长症状持续时间与缓解几率降低独立相关。
核心结论
- 自2018年以来英格兰和威尔士早期RA全国缓解率保持稳定,但地区和医院层面差异显著,凸显服务提供中的持续不平等。
- 改善缓解率需要解决转诊至治疗时间之外的因素,特别是延迟就诊初级保健。
研究设计与样本
- 观察性队列研究,使用2018年5月至2024年4月NEIAA数据,纳入新诊断RA个体。
- 采用中断时间序列和病例组合调整混合效应回归分析缓解率(DAS28<2.6)的时间与地理差异,多变量logistic回归评估缓解预测因素。
- 21904例RA患者中13752例(62.8%)有初次风湿科评估后3个月DAS28数据。
主要发现
- 13752例有3个月DAS28数据的患者中4764例(34.6%)达到缓解。
- 全国缓解率2018至2024年稳定,地理范围从伦敦28.4%到英格兰东部40.3%。
- 地区内各医院间缓解率相差三倍。
- 较年轻、女性、Black ethnicity、较高基线DAS28、延迟启用DMARD及较长症状持续时间与缓解几率降低独立相关。
- 自COVID-19大流行以来,症状发作至转诊的延迟增加。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Considerable data support early treatment of RA to obtain disease remission. Data from the National Early Inflammatory Arthritis Audit (NEIAA) in England and Wales suggest that, despite recent improvements in referral-to-treatment times, remission rates remain unchanged. We investigated reasons for this disconnect by evaluating temporal trends, geographical variation and predictors of remission in individuals with new RA diagnoses. METHODS: An observational cohort study of individuals with RA was conducted using data from NEIAA (May 2018-April 2024). Temporal and geographical variation in remission rates (DAS28 < 2.6) were explored using interrupted time-series and case-mix-adjusted mixed-effects regression. Predictors of remission were assessed using multivariable logistic regression. RESULTS: 13 752 of 21 904 (62.8%) individuals with RA had data on DAS28 at 3 months after initial rheumatology assessment, of whom 4764 (34.6%) achieved remission. National remission rates were stable from 2018 to 2024; however, wide geographical variation was observed, ranging from 28.4% (London) to 40.3% (East of England). Threefold differences in remission rates were seen between individual hospitals within regions. Younger age, female sex, Black ethnicity, higher baseline DAS28, delayed DMARD initiation and longer symptom duration were independently associated with reduced odds of remission. Delays between symptom onset and referral have increased since the COVID-19 pandemic. CONCLUSION: While national remission rates for early RA have remained stable in England and Wales since 2018, there is marked regional and hospital-level variation, highlighting ongoing inequities in service delivery. Addressing factors beyond referral-to-treatment time-particularly delayed presentation to primary care-is required to improve remission rates.
引用
- Alveyn E, Coalwood C, Farrell G, et al. Trends in remission rates for rheumatoid arthritis in England and Wales: a population-level cohort study. Rheumatology (Oxford). 2025. PMID: 40323317. doi:10.1093/rheumatology/keaf233
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。